Ute Ganswindt
Overview
Explore the profile of Ute Ganswindt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
2837
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mangesius J, Hormandinger K, Jager R, Skvortsov S, Plankensteiner M, Maffei M, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509257
This study aims to investigate the effect of dose escalation with brachytherapy (BT) as an addition to definitive chemoradiotherapy (CRT) on local control and survival in esophageal cancer. From 2001...
12.
Unger K, Hess J, Link V, Buchner A, Eze C, Li M, et al.
Clin Transl Radiat Oncol
. 2023 Mar;
39:100586.
PMID: 36935856
Purpose: In prostate cancer, the indication to irradiate the pelvic lymphatic pathways in clinical node-negative patients is solely based on clinical nomograms. To define biological risk patterns of lymphatic spread,...
13.
Hocht S, Bohmer D, Wiegel T, Ganswindt U
Urologie
. 2023 Feb;
62(3):299-301.
PMID: 36853507
No abstract available.
14.
Trapp C, Oliinyk D, Rogowski P, von Bestenbostel R, Ganswindt U, Li M, et al.
J Nucl Med
. 2023 Feb;
64(6):918-923.
PMID: 36732055
Salvage elective nodal radiotherapy (ENRT) is a treatment option for patients with biochemically persistent or recurrent prostate cancer who have lymph node metastases (LNs) after prostatectomy. Possible ENRT templates were...
15.
Savic D, Steinbichler T, Ingruber J, Negro G, Aschenbrenner B, Riechelmann H, et al.
Cells
. 2023 Jan;
12(2).
PMID: 36672272
Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently, ferroptosis was shown to be a promising...
16.
Mangesius J, Mangesius S, Demetz M, Uprimny C, di Santo G, Galijasevic M, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551750
Radiation necrosis represents a potentially devastating complication after radiation therapy in brain tumors. The establishment of the diagnosis and especially the differentiation from progression and pseudoprogression with its therapeutic implications...
17.
Mangesius J, Minasch D, Fink K, Nevinny-Stickel M, Lukas P, Ganswindt U, et al.
Strahlenther Onkol
. 2022 Dec;
199(1):67-77.
PMID: 36515701
Purpose: A major complication of sequential and concomitant chemoradiation in breast cancer treatment is interstitial pneumonitis induced by radiation therapy (RT), systemic therapy, or a combination of both. Dose and...
18.
Bohmer D, Wiegel T, Hocht S, Ganswindt U
Urologie
. 2022 Oct;
61(12):1387-1389.
PMID: 36260116
No abstract available.
19.
Meneghetti A, Zwanenburg A, Linge A, Lohaus F, Grosser M, Baretton G, et al.
Sci Rep
. 2022 Oct;
12(1):16755.
PMID: 36202941
Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) may benefit from personalised treatment, requiring biomarkers that characterize the tumour and predict treatment response. We integrate pre-treatment CT...
20.
Hess J, Unger K, Maihoefer C, Schuttrumpf L, Weber P, Marschner S, et al.
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954409
Human papillomavirus (HPV)-driven head and neck squamous cell carcinomas (HNSCC) generally have a more favourable prognosis. We hypothesized that HPV-associated HNSCC may be identified by an miRNA-signature according to their...